In a recent study conducted by a team from the University of California, San Francisco (UCSF), including Iris H. Liu, MD, Rym El Khoury, MD, Jade S. Hiramoto, MD MAS, Warren J. Gasper, MD, Peter A. Schneider, MD, Shant M. Vartanian, MD, and Michael S. Conte, MD, the relevance of the BEST-CLI trial endpoints was... Continue Reading →